http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1309028-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd617dc43a4c986d2dd81e4cb39d9dd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B21C23-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B21C23-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-55
filingDate 1988-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2d66afc02f6dc3e714a0cc9fd2f22e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c1176c163ddd5c44dd912adbe66b49d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_667c43771370e1433fdb98b76f539f3f
publicationDate 1992-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1309028-C
titleOfInvention Treating agent for heart failure
abstract ABSTRACT OF THE DISCLOSURE A preventing and treating agent for heart failure is disclosed, which comprises a compound represented by formula (I): (I) wherein R represents an imidazolyl group, a thiazolyl group or a pyridyl group; n represents 1 or 2; and m represents an integer of from 1 to 4, or a pharmaceutically acceptable salt thereof as an active ingredient.
priorityDate 1987-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508588

Total number of triples: 42.